Chak Hua Yew
Fortune : 2 269 $ au 31/10/2026
Fortune : 2 269 $ au 31/10/2026
Chak Hua Yew was an Independent Non-Executive Director at BioNexus Gene Lab Corp.
from 2022 to 2023.
Education includes an undergraduate degree from the University of Malaysia in 2007 and a graduate degree from UCSI University in 2014.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 2 469 ( 0,02% ) | 2 269 $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMED THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 18/04/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIONEXUS GENE LAB CORP. | Directeur/Membre du Conseil | 11/12/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Malaysia
University of Malaysia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCSI University
UCSI University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. Wholesale DistributorsDistribution Services Distributes chemical raw materials | Distribution Services |
CytoMed Therapeutics Ltd.
CytoMed Therapeutics Ltd. BiotechnologyHealth Technology Operates as a pre-clinical biopharmaceutical company that focuses on harnessing licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national